Media

Your hub to the latest Knowledge in Nuclear Medicine/Molecular Imaging

Press releases

Hermes Medical Solutions is proud to introduce HERMIA, a new version of its all-in-one molecular imaging software

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, is now introducing HERMIA, a new version of its ALL-IN-ONE Molecular Imaging Software with many exciting functionality updates.

SUV SPECT® Quantitative Reconstruction From Hermes Medical Solutions Evaluated Best-in-class for SIRT With Ho-166 Microspheres

Hermes Medical Solutions (HMS), leader in molecular imaging software development, has been recognized by Quirem Medical, a Terumo company, to provide the best commercially available and fully approved software for accurate quantitative reconstruction of 166Ho SPECT/CT scans for use with their exciting SIRT products QuiremScout® and QuiremSpheres®.

Hermes Medical Solutions & Isotopia Molecular Imaging Announce a New Collaboration Focused on Dosimetry

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, enters a close collaboration with Isotopia to raise awareness and co-promote benefits of dosimetry, radiopharmaceutical therapy (RPT) and personalized medicine.

Scientific publications

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.

The aim of this study was to compare reprojected bone SPECT/CT (RBS) against planar bone scintigraphy (BS) in the detection of bone metastases in breast and prostate cancer patients.

Comparing calculated and experimental activity and dose values obtained from image-based quantification of Y-90 SPECT/CT Data.

Selective internal radiation therapy (SIRT) is a treatment for various kinds of liver tumours by injecting Y-90 bearing microspheres into the liver vessels. To perform meaningful post-treatment dosimetry, quantitative imaging is performed.

Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients.

Delineation of PSMA-positive tumor volume on PET using PSMA-ligands is of highest clinical interest as changes of PSMA-PET/CT-derived whole tumor volume (WTV) have shown to correlate with treatment response in metastatic prostate cancer patients.

Brochures

Hermia product overview

Product overview of Hermia, a state-of-the-art software suite that supports all clinical scenarios in NM/MI on all cameras.

Future Liver Remnant Function

Ensure the best outcome for your patients undergoing major liver resection